SLC30A10 Knockout Huh-7 Cell Line
Cat.No.:
EDC07857
Species:
Human
Cell Name:
Huh-7
Gene:
SLC30A10
Gene ID:
55532
Size:
1×10⁶cells
SLC30A10 Knockout HuH-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07857 |
|---|---|
| Product Name | SLC30A10 Knockout HuH-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene ID | |
| Gene | SLC30A10 |
| Summary |
This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]
|
| Associated Diseases | Hepatocellular Carcinoma |
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:4 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 70% complete culture medium+20% FBS+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC30A10 function, SLC30A10 Knockout Huh-7 Cell Line or SLC30A10 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC30A10 (ZnT10)'s role in manganese efflux or modeling parkinsonism with hypermanganesemia. The Knockout line is the standard tool for asking whether SLC30A10 is required for cellular manganese extrusion — despite its SLC30 'zinc transporter' family designation, SLC30A10 is the principal cellular manganese efflux transporter, distinct from other ZnT family members. Overexpression is useful for testing manganese transport activity in heterologous systems and for rescue with disease-associated mutations.
For manganese biology research, the EDITGENE SLC30A10 Knockout in Huh-7 is highly relevant — hepatic SLC30A10 mediates biliary manganese excretion, and its loss-of-function causes hepatic cirrhosis, dystonia, parkinsonism, and polycythemia (HMNDYT1, hypermanganesemia with dystonia type 1). Rescue with wild-type, transport-deficient, or patient-derived mutant SLC30A10 enables comprehensive disease modeling. This product is particularly valuable for manganese-related neurodegenerative disease research.
What are the application scenarios for this model?
Primary applications:
• Manganese efflux assays: ICP-MS-based intracellular manganese measurement or Mn²⁺-sensitive fluorescent probe imaging following Mn²⁺ loading.
• Biliary manganese excretion modeling: SLC30A10-dependent Mn²⁺ extrusion in hepatocyte-derived contexts.
• HMNDYT1 disease modeling: rescue with patient-derived SLC30A10 mutations (e.g., L89P, T196P) for genotype-function correlation in this autosomal recessive disorder.
• Parkinsonism mechanism research: studies of manganese-induced neurotoxicity and disease relevance.
EDITGENE recommends this model for researchers investigating manganese homeostasis, hepatic Mn²⁺ excretion, and HMNDYT1/parkinsonism with hypermanganesemia disease mechanisms.
Is this SLC30A10 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes. SLC30A10 rescue experiments are well-established for manganese biology research:
• Construct design: use a codon-modified SLC30A10 sequence with a small C-terminal tag (FLAG, HA). The 6 transmembrane ZnT family architecture must be preserved.
• Disease mutation rescue: HMNDYT1-associated patient mutations (L89P, T196P, frameshift mutations) enable comprehensive disease genotype-function studies.
• Surface localization validation: confirm plasma membrane localization by cell surface biotinylation — many disease mutations cause trafficking defects.
• Functional readout: rescue should restore cellular manganese efflux measured by ICP-MS or Mn²⁺ fluorescent probes following manganese loading.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatocyte-derived background appropriate for biliary Mn²⁺ excretion studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download